CIRM is governed by 35 dedicated Californians representing patients, researchers and the biotechnology industry whose knowledge, passion and commitment to CIRM’s mission has guided the organization ...

ICOC Governing Board/Application Review Subcommittee June 27, 2024 Transcripts Minutes ...

BACKGROUND: The regulation of gene expression is complex and occurs at many levels, including transcriptional and post-transcriptional, in metazoans. Transcriptional regulation is mainly determined by ...

Sponsored by the California Institute for Regenerative Medicine (CIRM) and hosted by Cedars-Sinai, the 7th Annual Alpha Clinics Network Symposium brings together a wide array of stakeholders, ...

David Higgins, PhD, earned his PhD in molecular biology and genetics from the University of Rochester in New York, followed by a postdoctoral fellowship at the National Cancer Institute before moving ...

What is the California Institute for Regenerative Medicine (CIRM)? CIRM, California’s Stem Cell Agency, was created by the voters of California in 2004 when they overwhelmingly passed Proposition 71, ...

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem ...

have the ability to divide and create an identical copy of themselves, a process called self-renewal; and can also divide to form cells that mature into cells that make up every type of tissue and ...

There is no shortage of myths and misconceptions when it comes to stem cell research and regenerative medicine. Here we address the most common concerns. If you have more questions that aren’t ...

The Application Review Subcommittee (ARS) reviews the Grants Working Group’s and Facilities Working Group’s recommendations for funding and makes decisions on applications for funding in public ...

Stem cells have the potential to treat a wide range of diseases. Here, discover why these cells are such a powerful tool for treating disease and what hurdles experts face before new therapies reach ...